ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,309.55
-1.10%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 이탈리아
  5. BIT
  6. Sanofi (SANF)

  7. Sanofi (SANF) 뉴스

SANF Sanofi

0.00
0.00 (0.00%)
- - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Sanofi SANF 이탈리아 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.00 0.00% -
개장가 저가 고가 종가 전일 종가
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202414:30GLOBEPress Release: Sanofi Q1: robust 7% sales growth driven by..
23/04/202414:00GLOBEPress Release: Rilzabrutinib LUNA 3 phase 3 study met..
17/04/202414:00GLOBEPress Release: New 48-week frexalimab phase 2 data support..
13/04/202403:05GLOBESanofi: Information concerning the total number of voting..
09/04/202401:00GLOBESanofi - AGM 30.04.2024 - Availability of Preparatory..
22/03/202415:30GLOBEPress Release: Availability of the Q1 2024 Memorandum for..
16/03/202404:04GLOBESanofi: Informations relatives au nombre de droits de vote..
11/03/202415:00GLOBECommuniqué de presse : De nouveaux résultats de phase II..
24/02/202423:51GLOBEPress Release: Phase 2 results demonstrate rilzabrutinib..
24/02/202402:45GLOBEPress Release: Filing of the 2023 U.S. Form 20-F and French..
23/02/202415:00GLOBEPress Release: Dupixent® sBLA accepted for FDA Priority..
23/02/202403:02GLOBECommuniqué de presse : Le Conseil d’administration de Sanofi..
21/02/202407:40GLOBESanofi: Informations relatives au nombre de droits de vote..
16/02/202415:00GLOBECommuniqué de presse : Le Japon est le premier pays dans le..
15/02/202422:00GLOBECommuniqué de presse : Des données de phase II publiées dans..
05/02/202416:00GLOBEPress Release: Peer support, flexible work arrangements,..
01/02/202415:30GLOBEPress Release: Sanofi Delivers Solid Sales and Business EPS..
26/01/202404:30GLOBECommuniqué de presse : Dupixent® : premier et seul..
23/01/202415:30GLOBECommuniqué de presse : Sanofi va acquérir Inhibrx, Inc. et..
18/01/202406:57GLOBESanofi: Information concerning the total number of voting..
09/01/202415:30GLOBEPress Release: Brian Foard appointed Head of Specialty Care..
21/12/202315:30GLOBEPress Release: Sanofi announces end of program evaluating..
19/12/202305:59GLOBESanofi: Information concerning the total number of voting..
15/12/202315:30GLOBEPress Release: Availability of the Q4 2023 Memorandum for..
15/12/202315:00GLOBECommuniqué de presse : L’EMA a rendu un avis favorable pour..
12/12/202306:08GLOBECommuniqué de presse : Déclaration au sujet de la..
11/12/202309:30GLOBECP : Sarclisa® (isatuximab) plus KRd améliore..
07/12/202315:35GLOBECP : L’essai de phase III consacré au Sarclisa® (isatuximab)..
07/12/202311:30GLOBEPress Release: Sanofi Pipeline Transformation to Accelerate..
27/11/202315:30GLOBECommuniqué de presse : Dupixent® a permis de réduire..
24/11/202302:00GLOBESanofi: Information concerning the total number of voting..
27/10/202314:31GLOBECommuniqué de presse : Un troisième trimestre solide, marqué..
27/10/202314:30GLOBECommuniqué de presse : Sanofi entame un nouveau chapitre de..
23/10/202304:00GLOBEPress Release: Dupixent® (dupilumab) Phase 3 Results show..
19/10/202319:00GLOBECommuniqué de presse : Sanofi livre les premiers médicaments..
18/10/202317:45GLOBECommuniqué de presse : Des données de ph III présentées au..
18/10/202303:18GLOBESanofi: Informations relatives au nombre de droits de vote..
13/10/202323:00GLOBECommuniqué de presse : Des données de phase IIb de dernière..
04/10/202314:00GLOBECommuniqué de presse : Sanofi et Teva annoncent une..
03/10/202314:30GLOBECommuniqué de presse : Sanofi annonce un accord sur un..
26/09/202314:30GLOBECommuniqué de presse : La FDA accorde un examen prioritaire..
25/09/202316:00GLOBEPress Release: Once-weekly ALTUVIIIO® approved in Japan as a..
22/09/202314:30GLOBEPress Release: Availability of the Q3 2023 Memorandum for..
19/09/202315:30GLOBECommuniqué de presse : Sanofi soutient les communautés..
12/09/202303:02GLOBESanofi: Information concerning the total number of voting..
31/08/202314:30GLOBEPress Release: Sanofi announces changes to its Executive..
16/08/202304:24GLOBESanofi: Information concerning the total number of voting..
04/08/202304:21GLOBEPress Release: U.S. CDC Advisory Committee unanimously..
28/07/202320:22GLOBEPress release: Online availability of Sanofi’s half-year..
28/07/202314:32GLOBEPress Release: Sanofi to acquire Qunol®, a fast-growing U.S...

최근 히스토리

BIT
SANF
Sanofi
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유